|
Cash flows from operating activities:
|
|
|
|
|
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
|
|
|
|
Net Income From Continuing Operations
|
|
—
|
$1.6m
|
($8.1m)
|
($11.9m)
|
($32.5m)
|
|
Net Income (Loss) Attributable to Parent
|
|
—
|
$1.6m
|
($8.1m)
|
($11.9m)
|
($32.5m)
|
|
Net Income (Loss) Available to Common Stockholders, Basic
|
|
—
|
$1.6m
|
($10.5m)
|
$0
|
$0
|
|
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
|
|
—
|
—
|
($8.1m)
|
($11.9m)
|
($32.5m)
|
|
Depreciation, Depletion and Amortization
|
|
—
|
$138k
|
$203k
|
$233k
|
$275k
|
|
Amortization of Intangible Assets
|
|
—
|
—
|
$30k
|
$27k
|
$0
|
|
Depreciation
|
|
—
|
$138k
|
$173k
|
$206k
|
$275k
|
|
Depreciation Amortization Depletion
|
|
—
|
$138k
|
$203k
|
$233k
|
$275k
|
|
Deferred Income Tax Expense (Benefit)
|
|
—
|
—
|
—
|
—
|
$0
|
|
Share-based Payment Arrangement, Noncash Expense
|
|
—
|
—
|
$7.5m
|
$7.0m
|
$20.9m
|
|
Share-based Payment Arrangement, Expense
|
|
—
|
—
|
$7.5m
|
$7.0m
|
$20.9m
|
|
Share-based compensation
|
|
—
|
—
|
$7.5m
|
$7.0m
|
$20.9m
|
|
Asset Impairment Charge
|
|
—
|
$272k
|
$474k
|
$464k
|
$532k
|
|
Gain (Loss) on Disposition of Property Plant Equipment
|
|
—
|
$8k
|
($2k)
|
—
|
—
|
|
Gain (Loss) on Extinguishment of Debt
|
|
—
|
—
|
—
|
$233k
|
—
|
|
Income (Loss) from Equity Method Investments
|
|
—
|
—
|
—
|
—
|
$12k
|
|
Operating lease liabilities
|
|
—
|
($270k)
|
($345k)
|
($458k)
|
($460k)
|
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
|
Additional Financial Items
|
|
|
|
|
|
|
|
Increase (Decrease) in Accounts Receivable
|
|
—
|
—
|
$5.1m
|
($668k)
|
($4.7m)
|
|
Increase (Decrease) in Inventories
|
|
—
|
—
|
$663k
|
$1.3m
|
$1.8m
|
|
Increase (Decrease) in Accounts Payable
|
|
—
|
—
|
($860k)
|
$2.4m
|
($2.1m)
|
|
Foreign Currency Transaction Gain (Loss), Unrealized
|
|
—
|
—
|
$206k
|
($218k)
|
$546k
|
|
General and Administrative Expense
|
|
—
|
—
|
$14.0m
|
$10.8m
|
$26.6m
|
|
Inventory Write-down
|
|
—
|
—
|
$156k
|
$43k
|
$5k
|
|
Operating Expenses
|
|
—
|
—
|
$24.5m
|
$33.3m
|
$44.3m
|
|
Net loss
|
|
—
|
$1.6m
|
($8.1m)
|
($11.9m)
|
($32.5m)
|
|
Allowance for credit losses
|
|
—
|
$323k
|
$185k
|
$127k
|
$825k
|
|
Write-down of inventories
|
|
—
|
$0
|
$156k
|
$43k
|
$5k
|
|
Reduction in the carrying amount of right-of-use assets
|
|
—
|
$272k
|
$318k
|
$421k
|
$527k
|
|
Changes in fair value of financial instruments
|
|
—
|
$191k
|
$1.5m
|
$88k
|
($128k)
|
|
Unrealized foreign currency transaction (gain) loss
|
|
—
|
($423k)
|
($206k)
|
$218k
|
($546k)
|
|
Accounts receivable
|
|
—
|
($3.6m)
|
($5.1m)
|
$668k
|
$4.7m
|
|
Amounts due from related parties
|
|
—
|
($256k)
|
($469k)
|
($1.3m)
|
($745k)
|
|
Inventories
|
|
—
|
($3.4m)
|
($663k)
|
($1.3m)
|
($1.8m)
|
|
Prepayments and other assets
|
|
—
|
($410k)
|
$167k
|
($4.7m)
|
$2.9m
|
|
Accounts payable
|
|
—
|
$4.1m
|
($860k)
|
$2.4m
|
($2.1m)
|
|
Contract liabilities
|
|
—
|
$1.2m
|
($1.5m)
|
$2.0m
|
$711k
|
|
Amounts due to a related party
|
|
—
|
—
|
—
|
$127k
|
$35k
|
|
Accrued expenses and other current liabilities
|
|
—
|
$1.5m
|
$1.6m
|
($689k)
|
($35k)
|
|
Other non-current liabilities
|
|
—
|
($8k)
|
$72k
|
$89k
|
($80k)
|
|
Proceeds from collection of the loan to a related party of a shareholder
|
|
—
|
$1.4m
|
$2.9m
|
$56k
|
—
|
|
Cash paid for purchase of property and equipment and intangible assets
|
|
—
|
($214k)
|
($526k)
|
($614k)
|
($677k)
|
|
Proceeds from short-term bank borrowings
|
|
—
|
$6.4m
|
$6.3m
|
$8.5m
|
$4.2m
|
|
Repayment of short-term bank borrowings
|
|
—
|
($3.8m)
|
($4.6m)
|
($7.3m)
|
($6.8m)
|
|
Interest free advances to the Founders and executive officers
|
|
—
|
($244k)
|
($705k)
|
—
|
—
|
|
Proceeds from collection of advances to the Founders and executive officers
|
|
—
|
—
|
$272k
|
$676k
|
—
|
|
Payments of initial public offering ("IPO") cost
|
|
—
|
($121k)
|
($1.5m)
|
($1.9m)
|
—
|
|
Payments of initial public offering ("IPO") cost and follow-up offering cost
|
|
—
|
—
|
($1.5m)
|
($1.9m)
|
($1.8m)
|
|
Accrual of IPO cost
|
|
—
|
$198k
|
—
|
$1.2m
|
—
|
|
Accrual of IPO and follow-up offering cost
|
|
—
|
—
|
—
|
$1.2m
|
$523k
|
|
Beginning Cash Position
|
|
—
|
$4.8m
|
$8.7m
|
$15.7m
|
$26.8m
|
|
Cash Flow From Continuing Financing Activities
|
|
—
|
$2.3m
|
$10.7m
|
$19.1m
|
($4.3m)
|
|
Cash Flow From Continuing Investing Activities
|
|
—
|
$1.2m
|
$2.3m
|
($534k)
|
($1.5m)
|
|
Change In Account Payable
|
|
—
|
$4.1m
|
($860k)
|
$2.4m
|
($2.1m)
|
|
Change In Accrued Expense
|
|
—
|
$1.5m
|
$1.6m
|
($689k)
|
($35k)
|
|
Change In Inventory
|
|
—
|
($3.4m)
|
($663k)
|
($1.3m)
|
($1.8m)
|
|
Change In Other Current Liabilities
|
|
—
|
($277k)
|
($274k)
|
($370k)
|
($540k)
|
|
Change In Other Working Capital
|
|
—
|
$1.2m
|
($1.5m)
|
$2.0m
|
$711k
|
|
Change In Payable
|
|
—
|
$4.1m
|
($860k)
|
$2.5m
|
($2.1m)
|
|
Change In Payables And Accrued Expense
|
|
—
|
$5.5m
|
$755k
|
$1.9m
|
($2.1m)
|
|
Change In Prepaid Assets
|
|
—
|
($410k)
|
$167k
|
($4.7m)
|
$2.9m
|
|
Change In Receivables
|
|
—
|
($3.9m)
|
($5.5m)
|
($662k)
|
$4.0m
|
|
Change In Working Capital
|
|
—
|
($1.2m)
|
($7.1m)
|
($3.2m)
|
$3.1m
|
|
Changes In Account Receivables
|
|
—
|
($3.6m)
|
($5.1m)
|
$668k
|
$4.7m
|
|
Changes In Cash
|
|
—
|
$4.3m
|
$7.4m
|
$11.4m
|
($13.4m)
|
|
End Cash Position
|
|
—
|
$8.7m
|
$15.7m
|
$26.8m
|
$13.9m
|
|
Financing Cash Flow
|
|
—
|
$2.3m
|
$10.7m
|
$19.1m
|
($4.3m)
|
|
Free Cash Flow
|
|
—
|
$635k
|
($6.1m)
|
($7.8m)
|
($8.2m)
|
|
Gain Loss On Sale Of PPE
|
|
—
|
$8k
|
$2k
|
$0
|
$0
|
|
Investing Cash Flow
|
|
—
|
$1.2m
|
$2.3m
|
($534k)
|
($1.5m)
|
|
Issuance Of Capital Stock
|
|
—
|
$0
|
$0
|
$19.1m
|
$0
|
|
Net Foreign Currency Exchange Gain Loss
|
|
—
|
($423k)
|
($206k)
|
$218k
|
($546k)
|
|
Net PPE Purchase And Sale
|
|
—
|
($214k)
|
($526k)
|
($614k)
|
($677k)
|
|
Net Preferred Stock Issuance
|
|
$15.9m
|
$0
|
$0
|
—
|
—
|
|
Operating Gains Losses
|
|
—
|
($415k)
|
($204k)
|
($15k)
|
($546k)
|
|
Other Non Cash Items
|
|
$219k
|
($72k)
|
—
|
—
|
$12k
|
|
Preferred Stock Issuance
|
|
$16.1m
|
$0
|
$0
|
—
|
—
|
|
Preferred Stock Payments
|
|
($181k)
|
$0
|
$0
|
—
|
—
|
|
Provisionand Write Offof Assets
|
|
—
|
$323k
|
$185k
|
$127k
|
$825k
|
|
Purchase Of PPE
|
|
—
|
($214k)
|
($526k)
|
($614k)
|
($677k)
|
|
Repurchase Of Capital Stock
|
|
($181k)
|
$0
|
$0
|
—
|
—
|
|
Stock Based Compensation
|
|
—
|
$0
|
$7.5m
|
$7.0m
|
$20.9m
|
|
Unrealized Gain Loss On Investment Securities
|
|
—
|
$191k
|
$1.5m
|
$88k
|
($128k)
|
|
Net Cash Provided by (Used in) Operating Activities
|
|
—
|
$849k
|
($5.6m)
|
($7.2m)
|
($7.5m)
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
Net Other Investing Changes
|
|
—
|
$1.4m
|
$2.8m
|
$80k
|
($822k)
|
|
Net Cash Provided by (Used in) Investing Activities
|
|
—
|
$1.2m
|
$2.3m
|
($534k)
|
($1.5m)
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
Issuance Of Debt
|
|
—
|
$6.4m
|
$17.4m
|
$15.5m
|
$4.2m
|
|
Net Issuance Payments Of Debt
|
|
—
|
$2.6m
|
$12.7m
|
$1.3m
|
($2.6m)
|
|
Net Short Term Debt Issuance
|
|
—
|
$2.6m
|
$12.7m
|
$1.3m
|
($2.6m)
|
|
Short Term Debt Issuance
|
|
—
|
$6.4m
|
$17.4m
|
$15.5m
|
$4.2m
|
|
Repayment Of Debt
|
|
—
|
($3.8m)
|
($4.6m)
|
($14.3m)
|
($6.8m)
|
|
Short Term Debt Payments
|
|
—
|
($3.8m)
|
($4.6m)
|
($14.3m)
|
($6.8m)
|
|
Proceeds from Issuance of Common Stock
|
|
—
|
—
|
—
|
$19.1m
|
—
|
|
Common Stock Issuance
|
|
—
|
$0
|
$0
|
$19.1m
|
$0
|
|
Net Common Stock Issuance
|
|
—
|
$0
|
$0
|
$19.1m
|
$0
|
|
Net Other Financing Charges
|
|
—
|
($365k)
|
($2.0m)
|
($1.2m)
|
($1.8m)
|
|
Net Cash Provided by (Used in) Financing Activities
|
|
—
|
$2.3m
|
$10.7m
|
$19.1m
|
($4.3m)
|
|
Effect of foreign currency exchange rate changes on cash and cash equivalents and restricted cash
|
|
—
|
($507k)
|
($411k)
|
($333k)
|
$487k
|
|
Effect Of Exchange Rate Changes
|
|
—
|
($507k)
|
($411k)
|
($333k)
|
$487k
|
|
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
|
|
—
|
—
|
$7.0m
|
$11.1m
|
($12.9m)
|
|
Net increase (decrease) in cash, cash equivalents and restricted cash
|
|
—
|
$3.8m
|
$7.0m
|
$11.1m
|
($12.9m)
|
|
Cash, cash equivalents and restricted cash at the beginning of the year
|
|
—
|
$8.7m
|
$15.7m
|
$26.8m
|
$13.9m
|
|
Supplemental disclosure of cash flow information:
|
|
|
|
|
|
|
|
Change In Cash Supplemental As Reported
|
|
—
|
$3.8m
|
$7.0m
|
$11.1m
|
($12.9m)
|
|
Interest Paid, Excluding Capitalized Interest, Operating Activities
|
|
—
|
$119k
|
$77k
|
$213k
|
$128k
|
|
Income Taxes Paid, Net
|
|
—
|
$0
|
$0
|
$83k
|
$45k
|